Canaccord analyst George Gianarikas lowered the firm’s price target on Aspen Aerogels to $18 from $20 and keeps a Buy rating on the shares. The analyst said Aspen reported a healthy quarter and more importantly, management also unveiled potential new EV wins on the horizon, designed to support its growth plans.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on ASPN:
- Aspen Aerogels sees FY23 EPS ($1.46)-($1.31), consensus ($1.10)
- Aspen Aerogels reports Q4 EPS (20c), consensus (30c)
- Aspen Aerogels, Inc. Reports Fourth Quarter and Fiscal 2022 Financial Results and Recent Business Developments
- Aspen Aerogels well positioned to ‘break out,’ says B. Riley
- Craig-Hallum uncovers ‘great buying opportunity’ after Friday’s confusion